Presentation TCT 2024 Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial Presenter: Wissam Jaber October 29, 2024
Presentation TCT 2024 ECLIPSE: A Large-scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation Presenter: Ajay Kirtane October 29, 2024
Presentation TCT 2024 TCT 519: Impact of Intravascular Imaging on Clinical Outcomes in the LIFE-BTK Randomized Controlled Trial Presenter: Hector Garcia-Garcia October 29, 2024
Presentation TCT 2024 CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction Presenter: Sanjit Jolly October 29, 2024
Presentation TCT 2024 Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial Presenter: Ulf Teichgräber October 29, 2024
Presentation TCT 2024 TTVR – is the Future! Lessons from Clinical Trials and Case Experiences Presenter: Azeem Latib October 29, 2024
Presentation TCT 2024 TCT 497: Sex-Specific Clinical Outcomes After Treatment of In-Stent Restenosis With the AGENT Paclitaxel-Coated Balloon: A Subgroup Analysis of the AGENT IDE Randomized Trial Presenter: Jennifer Tremmel October 29, 2024
Presentation TCT 2024 How Can Clinical Trials Mobilize the Diversity Efforts? Presenter: Roxana Mehran October 29, 2024
Presentation TCT 2024 What am I Most Anticipating in Upcoming Clinical Trials? Presenter: Eric Secemsky October 29, 2024
Presentation TCT 2024 Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches Presenter: Behnood Bikdeli October 29, 2024
Presentation TCT 2024 TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials Presenter: Lei Song October 29, 2024
Presentation TCT 2024 Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial Presenter: Samir Kapadia October 29, 2024
Presentation TCT 2024 Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials Presenter: Didier Tchetche October 29, 2024
Presentation TCT 2024 Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial Presenter: Tobias Rheude October 29, 2024
Presentation TCT 2024 Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial Presenter: Thomas Pilgrim October 29, 2024
Presentation TCT 2024 The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation Presenter: Torsten Vahl October 29, 2024
Presentation TCT 2024 The EARLY TAVR Trial Editorial Commentary Presenter: Bernard Prendergast October 28, 2024
Presentation TCT 2024 Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis Presenter: Mark Dweck October 28, 2024